
Cello World Q1 FY27 Results: Revenue Rs 526 Cr, PAT Rs 73 Cr and Key Highlights
Cello World Q1 FY27 results declared August 7, 2026. Revenue Rs 526 Cr (-0.43% YoY). PAT Rs 73 Cr (-8.99% YoY). CMP Rs 373.15 (-1.61%).
Updated: 12 Aug 2026 • 12:30 pm
Posted by:

Cello World Q1 FY27 results were declared on August 7, 2026, consolidated. Revenue declined -0.43% YoY to Rs 526 Cr from Rs 529 Cr in Q1 FY26.
Operating profit stood at Rs 77 Cr (-14.65% YoY). PAT came in at Rs 73 Cr (-8.99% YoY), providing a detailed view of Cello World Q1 FY27 results and business performance.
Click Here – Get Free Investment Predictions
Cello World Q1 FY27 Financial Highlights
| Metric | Q1 FY27 (Rs Cr) | Q1 FY26 (Rs Cr) | YoY Change |
|---|---|---|---|
| Cello World Revenue | 526 | 529 | -0.43% |
| Operating Profit | 77 | 90 | -14.65% |
| Net Profit (PAT) | 73 | 80 | -8.99% |
| Reporting Basis | Consolidated | ||
Cello World Q1 FY27 Performance Analysis
Check the Univest Screener for Live Data on This Stock
Cello World Q1 FY27 results reflect modest fundamentals across key financial metrics. The top line faced near-term headwinds with revenue reaching Rs 526 Cr for the April to June 2026 quarter.
Operating profit contracted -14.65% YoY to Rs 77 Cr. Management is focused on cost rationalisation to restore operating leverage.
PAT of Rs 73 Cr in Cello World Q1 FY27 results marks a -8.99% YoY movement. Investors monitoring Cello World Q1 FY27 results will note this as a key milestone for the FY27 earnings trajectory.
Key Business Factors in Cello World Q1 FY27 Results
Revenue Normalisation After Near-Term Headwinds
Cello World Q1 FY27 results show top-line moderation, with revenue at Rs 526 Cr (-0.43% YoY). Management is focused on recalibrating its go-to-market strategy to address near-term demand softness.
Operating Profit Under Cost Headwinds
Operating profit in Cello World Q1 FY27 results came in at Rs 77 Cr (-14.65% YoY). Input cost inflation and competitive pricing dynamics weighed on operating profitability.
PAT Trajectory and Profitability Outlook
PAT in Cello World Q1 FY27 results stood at Rs 73 Cr (-8.99% YoY). Management is implementing cost optimisation and revenue diversification to improve profitability.
Dividend Details
No dividend was declared alongside Cello World Q1 FY27 results. Earnings are being directed toward operational investments and working capital optimisation.
FY27 Outlook for Cello World
Following Cello World Q1 FY27 results, management has reaffirmed a recovery-focused strategy centred on cost rationalisation, revenue diversification, and return to profitability. Progress in the consumer goods segment will be closely monitored by investors tracking Cello World Q1 FY27 results. Consult a SEBI-registered financial advisor before making decisions.
Cello World Stock Performance After Q1 FY27 Results
Download the Univest iOS App or Univest Android App to track Cello World live price and get daily stock recommendations.
Cello World shares were trading lower at Rs 373.15 (-1.61%) on August 7, 2026, reflecting investor sentiment on Cello World Q1 FY27 results and the near-term sector outlook. The CMP of Rs 373.15 on the results date reflects broader sentiment in the consumer goods space.
Key Risks for Cello World
Sector-Specific Risks
Consumer sentiment shifts and competitive pricing from unorganised players.
Valuation and Earnings Risk
Sustained margin compression and limited near-term earnings visibility may delay stock re-rating.
Operational and Financial Risk
Subsidiary-level underperformance could drag consolidated PAT lower in subsequent quarters.
Conclusion
Cello World Q1 FY27 results reflect modest performance with revenue at Rs 526 Cr and PAT at Rs 73 Cr on a Consolidated basis. Sector tailwinds and operational discipline will determine the FY27 growth trajectory. Investors should review management commentary and quarterly data before taking any position.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Cello World Q1 FY27 Results
When were Cello World Q1 FY27 results declared?
Ans. Cello World Q1 FY27 results were declared on August 7, 2026, covering the April–June 2026 quarter on a Consolidated basis.
What was Cello World revenue in Q1 FY27?
Ans. Cello World Q1 FY27 results show revenue of Rs 526 Cr, -0.43% compared to Rs 529 Cr in Q1 FY26.
What was Cello World PAT in Q1 FY27?
Ans. Net profit in Cello World Q1 FY27 results was Rs 73 Cr, -8.99% year-on-year.
Did Cello World declare a dividend in Q1 FY27?
Ans. No dividend was announced alongside Cello World Q1 FY27 results. Check official NSE and BSE announcements for updates.
What is the FY27 outlook for Cello World?
Ans. Management has guided operational restructuring and return to profitability for FY27. Sector trends will remain key monitorables.
How did Cello World stock react to Q1 FY27 results?
Ans. Cello World shares were lower at Rs 373.15 (-1.61%) on August 7, 2026. Consult a SEBI-registered advisor before acting on price movements.
Recent Articles

Sofcom Systems Q1 FY27 Results: Revenue Rs 0.04 Cr, Net Loss Rs 0.06 Cr and Key Highlights
12 August 2026

Austin Engineering Q1 FY27 Results: Revenue Rs 32 Cr, PAT Rs 0.94 Cr and Key Highlights
12 August 2026

Shanmuga Hospital Q1 FY27 Results: Revenue Rs 11 Cr, PAT Rs 0.99 Cr and Key Highlights
12 August 2026

Sandu Pharma Q1 FY27 Results: Revenue Rs 16 Cr, PAT Rs 0.23 Cr and Key Highlights
12 August 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Sofcom Systems Q1 FY27 Results: Revenue Rs 0.04 Cr, Net Loss Rs 0.06 Cr and Key Highlights
Austin Engineering Q1 FY27 Results: Revenue Rs 32 Cr, PAT Rs 0.94 Cr and Key Highlights
Shanmuga Hospital Q1 FY27 Results: Revenue Rs 11 Cr, PAT Rs 0.99 Cr and Key Highlights
Sandu Pharma Q1 FY27 Results: Revenue Rs 16 Cr, PAT Rs 0.23 Cr and Key Highlights
Manugraph India Q1 FY27 Results: Revenue Rs 25 Cr, PAT Rs 7 Cr and Key Highlights
Popular this week
Raj Television Network Q1 FY27 Results: Revenue Rs 14 Cr, Net Loss Rs 1 Cr and Key Highlights

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





